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WHAT WE DO
Outbreak Response
VSPB conducts outbreak responses nationally and internationally, and  
develops, evaluates, and improves methods for the treatment, prevention, 
and laboratory diagnosis of hazardous disease agents. VSPB works with the 
familiar viruses such as Ebola and hantavirus, as well as the viruses causing 
the following diseases:
CS258350A
 • Marburg hemorrhagic fever
 • Crimean-Congo hemorrhagic fever (CCHF)
 • Hemorrhagic fever with renal syndrome 
(HFRS)
 • Rift Valley fever (RVF)
 • Lymphocytic choriomeningitis (LCM)
 • Lujo hemorrhagic fever (LUHF)
 • Lassa fever 
 • Chapare hemorrhagic fever (CHHF)
 • Kyasanur Forest disease (KFD)
 • Alkhurma hemorrhagic fever (AHF)
 • Tick-borne encephalitis
 • Omsk hemorrhagic fever (OHF)
 • Hendra virus disease
 • Nipah virus encephalitis
Virology
The Branch focuses on the isolation, 
identification, and characterization of these 
viruses, all of which require biosafety level 3 or 
biosafety level 4 laboratory conditions for safe 
handling. Branch staff conduct laboratory, clinical, 
ecological, and epidemiologic investigations on 
the pathogenesis and pathophysiology of these 
viruses, and provide consultation to hospitals 
and clinical teams for management of patients. 
The Branch has recently developed a successful 
vaccine against Rift Valley Fever for livestock.
Collaboration
VSPB  consults with national 
and international scientists 
on the design, staffing, 
and efficient operation 
of high hazard pathogen 
laboratories,  serving as 
a WHO Collaborating 
Center for Virus Reference 
and Research for Viral 
Hemorrhagic Fevers. 
Education
The Branch develops, implements, and evaluates 
health education programs for educating the 
general public as well as health professionals 
about infection, treatment, infection control, 
prevention, and laboratory diagnosis of highly 
hazardous viral diseases. 
Outbreak Investigations
The Branch has responded to many outbreak 
investigations over the past several decades, 
providing laboratory and epidemiological 
investigations to aid in developing, evaluating, 
and improving methods for the treatment, 
prevention, and laboratory diagnosis of 
hazardous disease agents. Most recently, VSPB 
has participated in the CDC Ebola outbreak 
response in both West Africa and the US. VSPB 
teams supported or directed epidemiologic 
responses and studies, diagnostic and laboratory 
support, and risk communication and health 
education activities.
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